Yumuşak Doku Tümörleri
Özet
Referanslar
Choi, Joon Hyuk, and Jae Y Ro. “The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.” Advances in anatomic pathology vol. 28,1 (2021): 44-58. doi:10.1097/PAP.0000000000000284
Merchant, Melinda S, and Crystal L Mackall. “Current approach to pediatric soft tissue sarcomas.” The oncologist vol. 14,11 (2009): 1139-53. doi:10.1634/theoncologist.2009-0160
Kapoor, Gauri, and Kunal Das. “Soft tissue sarcomas in children.” Indian journal of pediatrics vol. 79,7 (2012): 936-42. doi:10.1007/s12098-011-0560-4
Córdoba Rovira, S M, and E J Inarejos Clemente. “Childhood rhabdomyosarcoma.” “Rabdomiosarcoma infantil.” Radiologia vol. 58,6 (2016): 481-490. doi:10.1016/j.rx.2016.09.003
Sbaraglia, Marta et al. “The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.” Pathologica vol. 113,2 (2021): 70-84. doi:10.32074/1591-951X-213
Board WCoTE. Soft Tissue and Bone Tumours. 5th Edition ed. Lyon: International Agency for Research on Cancer (IARC); 2020.
Ferrari A, Orbach D, Sultan I, et al. “Neonatal soft tissue sarcomas.” Seminars in fetal & neonatal medicine vol. 17,4 (2012): 231-238. doi:10.1016/j.siny.2012.05.003
de Bonilla-Damiá A, Fernández-López R, Pachón-Garrudo VM, et al. “18F-FDG PET/CT as staging of alveolar rhabdomyosarcoma.” “18F-FDG PET/TC en la estadificación inicial de pacientes con rabdomiosarcoma alveolar.” Medicina clinica vol. 150,4 (2018): e7. doi:10.1016/j.medcli.2017.03.048
D’cruze L, Dutta R, Rao S, et al. “The role of immunohistochemistry in the analysis of the spectrum of small round cell tumours at a tertiary care centre.” Journal of clinical and diagnostic research : JCDR vol. 7,7 (2013): 1377-82. doi:10.7860/JCDR/2013/5127.3132
Eguía-Aguilar P, López-Martínez B, Retana-Contreras C, et al. “Alveolar rhabdomyosarcoma: origin and prognostic implications of molecular findings.” Boletin medico del Hospital Infantil de Mexico vol. 73,6 (2016): 405-410. doi:10.1016/j.bmhimx.2016.09.001
Mestre-Alagarda C, Gómez-Mateo MC, Berenguer-Romero MD, et al. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1]. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia. 2022;55(1):57-62.
Franchi A. [Rhabdomyosarcoma]. Pathologica. 2000;92(2):122-3.
Bisogno, Gianni, and Douglas S Hawkins. “An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.” Pediatric blood & cancer vol. 67,5 (2020): e28174. doi:10.1002/pbc.28174
Ferrari A, Brennan B, Casanova M, et al. “Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).” Cancer management and research vol. 14 2885-2902. 23 Sep. 2022, doi:10.2147/CMAR.S368381
Dean A, Byrne A, Marinova M, et al. “Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling.” BioMed research international vol. 2016 (2016): 4627214. doi:10.1155/2016/4627214
Eaton BR, Claude L, Indelicato DJ, et al. “Ewing sarcoma.” Pediatric blood & cancer vol. 68 Suppl 2 (2021): e28355. doi:10.1002/pbc.28355
Balamuth, Naomi J, and Richard B Womer. “Ewing's sarcoma.” The Lancet. Oncology vol. 11,2 (2010): 184-92. doi:10.1016/S1470-2045(09)70286-4
Gargallo P, Yáñez Y, Juan A, et al. “Review: Ewing Sarcoma Predisposition.” Pathology oncology research : POR vol. 26,4 (2020): 2057-2066. doi:10.1007/s12253-019-00765-3
Brennan B, Kirton L, Marec-Bérard P, et al. “Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.” Lancet (London, England) vol. 400,10362 (2022): 1513-1521. doi:10.1016/S0140-6736(22)01790-1
Lai B, Siyi L, Zhou J, et al. “Desmoplastic small round-cell tumor.” Asian journal of surgery vol. 47,4 (2024): 2021-2022. doi:10.1016/j.asjsur.2024.01.038
Chang, Chung-Che, and Vinod B Shidham. “Molecular genetics of pediatric soft tissue tumors: clinical application.” The Journal of molecular diagnostics : JMD vol. 5,3 (2003): 143-54. doi:10.1016/S1525-1578(10)60466-7
Mello CA, Campos FAB, Santos TG, et al. “Desmoplastic Small Round Cell Tumor: A Review of Main Molecular Abnormalities and Emerging Therapy.” Cancers vol. 13,3 498. 28 Jan. 2021, doi:10.3390/cancers13030498
Blay JY, von Mehren M, Jones RL, et al. “Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies.” ESMO open vol. 8,5 (2023): 101618. doi:10.1016/j.esmoop.2023.101618
Beena D, Kattoor J, Mathews A, et al. “Mesenchymal Chondrosarcoma-A Retrospective study.” The Gulf journal of oncology vol. 1,35 (2021): 54-58.
Syed M, Mushtaq S, Loya A, et al. “NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.” Annals of diagnostic pathology vol. 50 (2021): 151660. doi:10.1016/j.anndiagpath.2020.151660
Dudzisz-Śledź M, Kondracka M, Rudzińska M, et al. “Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials.” Cancers vol. 15,18 4581. 15 Sep. 2023, doi:10.3390/cancers15184581
Jaber, Omar I, and Patricia A Kirby. “Alveolar Soft Part Sarcoma.” Archives of pathology & laboratory medicine vol. 139,11 (2015): 1459-62. doi:10.5858/arpa.2014-0385-RS
Fujiwara T, Kunisada T, Nakata E, et al. “Advances in treatment of alveolar soft part sarcoma: an updated review.” Japanese journal of clinical oncology vol. 53,11 (2023): 1009-1018. doi:10.1093/jjco/hyad102
Knight SWE, Knight TE, Santiago T, et al. “Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.” Children (Basel, Switzerland) vol. 9,1 38. 1 Jan. 2022, doi:10.3390/children9010038
Friedman JM. Neurofibromatosis 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.
Noreña-Rengifo BD, Cadavid-Alvarez LM, Gil-Serrano PE, et al. “Malignant peripheral nerve sheath tumor in a child.” Radiology case reports vol. 16,1 145-151. 12 Nov. 2020, doi:10.1016/j.radcr.2020.10.028
Dermawan, Josephine K. “Myxoid Pleomorphic Liposarcoma.” Surgical pathology clinics vol. 17,1 (2024): 25-29. doi:10.1016/j.path.2023.06.005
Ho TP. “Myxoid Liposarcoma: How to Stage and Follow.” Current treatment options in oncology vol. 24,4 (2023): 292-299. doi:10.1007/s11864-023-01064-5
da Silva TSG, de Santana IHG, Martins HDD, et al. “Small cell osteosarcoma in gnathic bones in the maxilla: case report in a pediatric patient.” Journal of cancer research and clinical oncology vol. 151,1 32. 7 Jan. 2025, doi:10.1007/s00432-024-06079-5
Amer HW, Algadi HH, Hamza SA. “Mandibular small cell osteosarcoma: a case report and review of literature.” Journal of the Egyptian National Cancer Institute vol. 35,1 30. 18 Sep. 2023, doi:10.1186/s43046-023-00191-2
Soler PM, Duque MSR, Juan GM, et al. “Intestinal infantile fibrosarcoma with translocation of NTRK. A case report and review of the literature.” Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia vol. 56,2 (2023): 76-81. doi:10.1016/j.patol.2022.09.004
Melendez-Zajgla J, Mercado-Celis GE, Gaytan-Cervantes J, et al. “Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome.” Scientific reports vol. 8,1 3252. 19 Feb. 2018, doi:10.1038/s41598-018-21663-9
Kunisada T, Nakata E, Fujiwara T, et al. “Soft-tissue sarcoma in adolescents and young adults.” International journal of clinical oncology vol. 28,1 (2023): 1-11. doi:10.1007/s10147-022-02119-7
Thway K, Jones RL, Noujaim J, et al. “Epithelioid Sarcoma: Diagnostic Features and Genetics.” Advances in anatomic pathology vol. 23,1 (2016): 41-9. doi:10.1097/PAP.0000000000000102
van Ewijk R, Schoot RA, Sparber-Sauer M, et al. “European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.” Pediatric radiology vol. 51,10 (2021): 1940-1951. doi:10.1007/s00247-021-05081-0
Rosenberg, Ari, and Mark Agulnik. “Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.” Current treatment options in oncology vol. 19,4 19. 15 Mar. 2018, doi:10.1007/s11864-018-0536-y
Mishima S, Mishima O, Azuhata K, “Angiomatoid fibrosis histiocytoma in the pulmonary artery: A case report.” Thoracic cancer vol. 12,9 (2021): 1453-1456. doi:10.1111/1759-7714.13929
Ibrahim RM, Steenstrup Jensen S, Juel J. “Clear cell sarcoma-A review.” Journal of orthopaedics vol. 15,4 963-966. 6 Sep. 2018, doi:10.1016/j.jor.2018.08.039
Nakano Y, Acker M, Druker H, et al. “Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance.” European journal of human genetics : EJHG vol. 32,11 (2024): 1474-1482. doi:10.1038/s41431-024-01674-z
Shah A, Paramesparan K, Robinson P, et al. “Non-neoplastic Soft Tissue Tumors and Tumor-like Lesions.” Seminars in musculoskeletal radiology vol. 24,6 (2020): 645-666. doi:10.1055/s-0040-1713606
Referanslar
Choi, Joon Hyuk, and Jae Y Ro. “The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.” Advances in anatomic pathology vol. 28,1 (2021): 44-58. doi:10.1097/PAP.0000000000000284
Merchant, Melinda S, and Crystal L Mackall. “Current approach to pediatric soft tissue sarcomas.” The oncologist vol. 14,11 (2009): 1139-53. doi:10.1634/theoncologist.2009-0160
Kapoor, Gauri, and Kunal Das. “Soft tissue sarcomas in children.” Indian journal of pediatrics vol. 79,7 (2012): 936-42. doi:10.1007/s12098-011-0560-4
Córdoba Rovira, S M, and E J Inarejos Clemente. “Childhood rhabdomyosarcoma.” “Rabdomiosarcoma infantil.” Radiologia vol. 58,6 (2016): 481-490. doi:10.1016/j.rx.2016.09.003
Sbaraglia, Marta et al. “The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.” Pathologica vol. 113,2 (2021): 70-84. doi:10.32074/1591-951X-213
Board WCoTE. Soft Tissue and Bone Tumours. 5th Edition ed. Lyon: International Agency for Research on Cancer (IARC); 2020.
Ferrari A, Orbach D, Sultan I, et al. “Neonatal soft tissue sarcomas.” Seminars in fetal & neonatal medicine vol. 17,4 (2012): 231-238. doi:10.1016/j.siny.2012.05.003
de Bonilla-Damiá A, Fernández-López R, Pachón-Garrudo VM, et al. “18F-FDG PET/CT as staging of alveolar rhabdomyosarcoma.” “18F-FDG PET/TC en la estadificación inicial de pacientes con rabdomiosarcoma alveolar.” Medicina clinica vol. 150,4 (2018): e7. doi:10.1016/j.medcli.2017.03.048
D’cruze L, Dutta R, Rao S, et al. “The role of immunohistochemistry in the analysis of the spectrum of small round cell tumours at a tertiary care centre.” Journal of clinical and diagnostic research : JCDR vol. 7,7 (2013): 1377-82. doi:10.7860/JCDR/2013/5127.3132
Eguía-Aguilar P, López-Martínez B, Retana-Contreras C, et al. “Alveolar rhabdomyosarcoma: origin and prognostic implications of molecular findings.” Boletin medico del Hospital Infantil de Mexico vol. 73,6 (2016): 405-410. doi:10.1016/j.bmhimx.2016.09.001
Mestre-Alagarda C, Gómez-Mateo MC, Berenguer-Romero MD, et al. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1]. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia. 2022;55(1):57-62.
Franchi A. [Rhabdomyosarcoma]. Pathologica. 2000;92(2):122-3.
Bisogno, Gianni, and Douglas S Hawkins. “An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.” Pediatric blood & cancer vol. 67,5 (2020): e28174. doi:10.1002/pbc.28174
Ferrari A, Brennan B, Casanova M, et al. “Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).” Cancer management and research vol. 14 2885-2902. 23 Sep. 2022, doi:10.2147/CMAR.S368381
Dean A, Byrne A, Marinova M, et al. “Clinical Outcomes of Patients with Rare and Heavily Pretreated Solid Tumors Treated according to the Results of Tumor Molecular Profiling.” BioMed research international vol. 2016 (2016): 4627214. doi:10.1155/2016/4627214
Eaton BR, Claude L, Indelicato DJ, et al. “Ewing sarcoma.” Pediatric blood & cancer vol. 68 Suppl 2 (2021): e28355. doi:10.1002/pbc.28355
Balamuth, Naomi J, and Richard B Womer. “Ewing's sarcoma.” The Lancet. Oncology vol. 11,2 (2010): 184-92. doi:10.1016/S1470-2045(09)70286-4
Gargallo P, Yáñez Y, Juan A, et al. “Review: Ewing Sarcoma Predisposition.” Pathology oncology research : POR vol. 26,4 (2020): 2057-2066. doi:10.1007/s12253-019-00765-3
Brennan B, Kirton L, Marec-Bérard P, et al. “Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.” Lancet (London, England) vol. 400,10362 (2022): 1513-1521. doi:10.1016/S0140-6736(22)01790-1
Lai B, Siyi L, Zhou J, et al. “Desmoplastic small round-cell tumor.” Asian journal of surgery vol. 47,4 (2024): 2021-2022. doi:10.1016/j.asjsur.2024.01.038
Chang, Chung-Che, and Vinod B Shidham. “Molecular genetics of pediatric soft tissue tumors: clinical application.” The Journal of molecular diagnostics : JMD vol. 5,3 (2003): 143-54. doi:10.1016/S1525-1578(10)60466-7
Mello CA, Campos FAB, Santos TG, et al. “Desmoplastic Small Round Cell Tumor: A Review of Main Molecular Abnormalities and Emerging Therapy.” Cancers vol. 13,3 498. 28 Jan. 2021, doi:10.3390/cancers13030498
Blay JY, von Mehren M, Jones RL, et al. “Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies.” ESMO open vol. 8,5 (2023): 101618. doi:10.1016/j.esmoop.2023.101618
Beena D, Kattoor J, Mathews A, et al. “Mesenchymal Chondrosarcoma-A Retrospective study.” The Gulf journal of oncology vol. 1,35 (2021): 54-58.
Syed M, Mushtaq S, Loya A, et al. “NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.” Annals of diagnostic pathology vol. 50 (2021): 151660. doi:10.1016/j.anndiagpath.2020.151660
Dudzisz-Śledź M, Kondracka M, Rudzińska M, et al. “Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials.” Cancers vol. 15,18 4581. 15 Sep. 2023, doi:10.3390/cancers15184581
Jaber, Omar I, and Patricia A Kirby. “Alveolar Soft Part Sarcoma.” Archives of pathology & laboratory medicine vol. 139,11 (2015): 1459-62. doi:10.5858/arpa.2014-0385-RS
Fujiwara T, Kunisada T, Nakata E, et al. “Advances in treatment of alveolar soft part sarcoma: an updated review.” Japanese journal of clinical oncology vol. 53,11 (2023): 1009-1018. doi:10.1093/jjco/hyad102
Knight SWE, Knight TE, Santiago T, et al. “Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.” Children (Basel, Switzerland) vol. 9,1 38. 1 Jan. 2022, doi:10.3390/children9010038
Friedman JM. Neurofibromatosis 1. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993.
Noreña-Rengifo BD, Cadavid-Alvarez LM, Gil-Serrano PE, et al. “Malignant peripheral nerve sheath tumor in a child.” Radiology case reports vol. 16,1 145-151. 12 Nov. 2020, doi:10.1016/j.radcr.2020.10.028
Dermawan, Josephine K. “Myxoid Pleomorphic Liposarcoma.” Surgical pathology clinics vol. 17,1 (2024): 25-29. doi:10.1016/j.path.2023.06.005
Ho TP. “Myxoid Liposarcoma: How to Stage and Follow.” Current treatment options in oncology vol. 24,4 (2023): 292-299. doi:10.1007/s11864-023-01064-5
da Silva TSG, de Santana IHG, Martins HDD, et al. “Small cell osteosarcoma in gnathic bones in the maxilla: case report in a pediatric patient.” Journal of cancer research and clinical oncology vol. 151,1 32. 7 Jan. 2025, doi:10.1007/s00432-024-06079-5
Amer HW, Algadi HH, Hamza SA. “Mandibular small cell osteosarcoma: a case report and review of literature.” Journal of the Egyptian National Cancer Institute vol. 35,1 30. 18 Sep. 2023, doi:10.1186/s43046-023-00191-2
Soler PM, Duque MSR, Juan GM, et al. “Intestinal infantile fibrosarcoma with translocation of NTRK. A case report and review of the literature.” Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia vol. 56,2 (2023): 76-81. doi:10.1016/j.patol.2022.09.004
Melendez-Zajgla J, Mercado-Celis GE, Gaytan-Cervantes J, et al. “Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome.” Scientific reports vol. 8,1 3252. 19 Feb. 2018, doi:10.1038/s41598-018-21663-9
Kunisada T, Nakata E, Fujiwara T, et al. “Soft-tissue sarcoma in adolescents and young adults.” International journal of clinical oncology vol. 28,1 (2023): 1-11. doi:10.1007/s10147-022-02119-7
Thway K, Jones RL, Noujaim J, et al. “Epithelioid Sarcoma: Diagnostic Features and Genetics.” Advances in anatomic pathology vol. 23,1 (2016): 41-9. doi:10.1097/PAP.0000000000000102
van Ewijk R, Schoot RA, Sparber-Sauer M, et al. “European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.” Pediatric radiology vol. 51,10 (2021): 1940-1951. doi:10.1007/s00247-021-05081-0
Rosenberg, Ari, and Mark Agulnik. “Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.” Current treatment options in oncology vol. 19,4 19. 15 Mar. 2018, doi:10.1007/s11864-018-0536-y
Mishima S, Mishima O, Azuhata K, “Angiomatoid fibrosis histiocytoma in the pulmonary artery: A case report.” Thoracic cancer vol. 12,9 (2021): 1453-1456. doi:10.1111/1759-7714.13929
Ibrahim RM, Steenstrup Jensen S, Juel J. “Clear cell sarcoma-A review.” Journal of orthopaedics vol. 15,4 963-966. 6 Sep. 2018, doi:10.1016/j.jor.2018.08.039
Nakano Y, Acker M, Druker H, et al. “Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance.” European journal of human genetics : EJHG vol. 32,11 (2024): 1474-1482. doi:10.1038/s41431-024-01674-z
Shah A, Paramesparan K, Robinson P, et al. “Non-neoplastic Soft Tissue Tumors and Tumor-like Lesions.” Seminars in musculoskeletal radiology vol. 24,6 (2020): 645-666. doi:10.1055/s-0040-1713606
